Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
Haemnet posted on LinkedIn:
”Shared decision-making is a real buzzword in modern haemophilia care. But how do you ensure that it moves beyond lip service to truly empower patients in decisions about their treatment?
This question underlies a new paper in The Journal of Haemophilia Practice, exploring the experience of people with haemophilia A switching from factor VIII prophylaxis to emicizumab.
The authors conducted in-depth qualitative interviews with participants with severe haemophilia A without FVIII inhibitors from the Swedish cohort of the HemiNorth 2 study. Alongside the process of ‘adapting to a new reality’ and a sense of normality, they found that ‘shattered expectations’ emerged as a key theme, highlighting gaps in knowledge among the patient group and the need to ensure that appropriate, patient-friendly information dis available to support treatment decisions.
Find out more, open access, in The Journal of Haemophilia
Practice here.”
Title: Perceived experiences of people with severe haemophilia A switching from factor VIII prophylaxis to emicizumab
Authors: Linda Myrin-Westesson, Anna Olsson
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 10:32Randall Schaefer: When Your Prehospital Agency Reports Blood Product Wastage Rates, What is it Really Reporting?
-
Oct 10, 2026, 10:26Simone Strasser: ROTEM-Guided Transfusion Cuts Blood Product Use in Patients with Cirrhosis
-
Oct 10, 2026, 10:18Jérôme S.: WHO Launches Global Roadmap to Combat Hypertensive Disorders of Pregnancy
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India
-
Oct 10, 2026, 09:52Yuria Ito: Should Ferritin Testing Become a Routine Part of Prenatal Care in Japan?
-
Oct 10, 2026, 09:48Ahmed Alotaibi: Can We “Remove” the ABO Problem from Group O Platelets?
-
Oct 10, 2026, 09:31Help Shape the New ASH Iron Deficiency Guidelines – American Society of Hematology
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health